Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Monday, July 29, 2024 · 731,296,455 Articles · 3+ Million Readers

Bone Grafts and Substitutes Market Set to Soar with 4.4% CAGR, Predicts US$ 4.4 billion by 2033

PORTLAND, OREGON, UNITED STATES, July 29, 2024 /EINPresswire.com/ -- Bone substitutes are synthetic materials that are designed to mimic the structure and function of natural bone. They are made from a variety of materials such as ceramics, metals, and polymers. These substitutes can be used alone or in combination with bone grafts to help promote bone growth and healing. They are used in a similar range of conditions as bone grafts such as spinal fusion, fracture repair and bone cancer treatment.

According to the report published by Allied Market Research, the global bone grafts and substitutes market was valued at $2.8 billion in 2023, and is projected to reach $4.4 billion by 2033, growing at a CAGR of 4.4% from 2024 to 2033.

Request Sample of the Report on - https://www.alliedmarketresearch.com/request-sample/1774

Key Takeaways:

The cell-based matrices segment, on the other hand, would display the fastest CAGR of 5.1% from 2024 to 2033.
The joint reconstruction segment would exhibit the fastest CAGR of 5.3% from 2024 to 2033.
The joint reconstruction segment would exhibit the fastest CAGR of 5.3% from 2024 to 2033.
Asia-Pacific would exhibit the fastest CAGR of 5.3% from 2024 to 2033.

The major factors driving the growth of the bone grafts and substitutes market are increase in number of road accidents & joint disorders, increase in demand of dental bone grafts and rise in geriatric population. Bone grafts and substitutes are often used to help heal bone fractures and other injuries caused by accidents. In addition, in many cases, they can be used to replace or repair damaged bone tissue, helping to restore normal function and mobility. Further, bone grafts and substitutes may be required in cases where the bone has been severely damaged or lost due to the accident. In these cases, bone grafts or substitutes can be used to help regenerate new bone tissue, which can help restore function and mobility of the affected area.

Drivers:

The rise in the number of spinal and joint construction surgeries and trauma cases

An increase in the incidence of orthopedic conditions

Opportunities:

Growth opportunities in emerging markets

Restraints:

The high cost of surgeries

Ethical & regulatory concerns related to bone grafting procedures

Factors affecting the growth of the Bone Grafts And Substitutes Market:

The increasing elderly population is more prone to orthopedic conditions like osteoporosis and fractures, driving the demand for bone grafts and substitutes.

Rising incidences of bone-related diseases and conditions, such as arthritis, traumatic fractures, and bone tumors, are propelling market growth.

The rise in sports activities and road accidents leads to an increase in bone fractures and injuries, which in turn drives the demand for bone grafts and substitutes.

Development and increasing use of biodegradable and biocompatible materials in bone grafts and substitutes are expected to foster market growth.

Connect to our Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1774

In terms of end user, the hospitals segment held the major market share in 2021, generating nearly three-fourths of the global bone grafts and substitutes market revenue, and is projected to rule the roost by 2031. However, the specialty clinics segment is expected to register the fastest CAGR of 5.0% from 2022 to 2031. The others segment is also explained in the report.

Key findings of the study:

On the basis of type, the bone graft substitutes segment was highest contributor to the market in 2023.

On the basis of application, the spinal fusion segment dominated the bone grafts and substitutes industry in terms of revenue in 2023. However, the joint reconstruction segment is anticipated to grow at the highest CAGR during the forecast period.

On the basis of end user, the hospitals segment dominated the bone grafts and substitutes industry in terms of revenue in 2023.

Region wise, North America generated the largest revenue in 2023. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.

For Procurement Information - https://www.alliedmarketresearch.com/purchase-enquiry/1774

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X

Powered by EIN Presswire


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release